Release Date: 01/10/14 17:45 Summary: Replacement Change in Substantial Shareholder Notice Price Sensitive: No Download Document 81.25KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%